| |
The Humanion UK Online Daily |
As the Mother Earth Belongs to Every Single Human Being
of the Humanion Regine Humanics Foundation Ltd and The
Humanion Belong to All for We are a Human Enterprise: A Not for
Profit Social Enterprise: Support Your Daily Quality Newspaper
and Let Us Build an Institution That Will Flow with Time with
the Rainbow Peoples of This Earth Far Into the Flowing
Future: Support
The Humanion:
Support
Regine Humanics Foundation Ltd
|
|
|
The Entire
Spectrum of Colours
and All the Forms,
Manners and
Expressions of Light
are Made Invisible
in This White: Or,
Rather, Mix All the
Colours and You Have
This White: Or,
Arrange All the
Colours and Find an
Infinite Rainbow: Or
Take the Colours and
Light Away and There
Resides the Darkness
But As Such That in
Its Invisible Sphere
There Still Remains
Another Infinite
Rainbow at Various
States, That We Can
Not See With Our
Eyes: Take That All
Away and You Have
the Utter, Absolute
and Primeval Duantum
Darkness Within
Which Our Matter
Universe is
Constructed and Does
Function: Unless, We
Remember This Every
Nano-Second of Our
Existence We Loose
Our Sense and Joy of
Eternal Wonder, Awe
and Astonishment of
This Magnificent
Universe, Which is
Outside, True, But
Which is Nano-Seismically
Constructed in the
Human Physiology and
Psychology: The
Study of Medicine
Will Always Remain
and Fall Short Until
It Sees and Learns
That It is Dealing
with the Universe,
When It Goes About
Learning and Healing
This Human
Physiology and
Psychology: Alphansum
Sovereign
Necessarius:
Munayem
Mayenin:
ISBN: 978-0-244-58241-8: April 14: 2020:
Imsonium Books
|
||
Wednesday: January
13: 2021 || ά.
Scientists at the
University of
Southampton's Centre
for Cancer
Immunology have
gained new insight
into how the immune
system can be better
used to find and
kill cancer cells.
Working with
Bio-Invent
International, a
team of researchers,
led by Professor
Mark Cragg and Dr
Jane Willoughby from
the Antibody and
Vaccine Group, have
shown that
antibodies, designed
to target the
molecule OX40, give
a more active immune
response when they
bind closer to the
cell membrane and
can be modified to
attack cancer in
different ways.
OX40 is a
‘co-receptor’, that
helps to stimulate
the production of
helper and killer
T-cells during an
immune response. One
of the ways cancer
avoids detection is
by suppressing
immune responses to
stop functional
tumour specific
T-cells from being
produced. In the
Study, which has
been published in
Journal for
ImmunoTherapy of
Cancer, the research
team, also,
discovered that
switching the
antibody’s isotype,
the part of the
antibody, that
engages with cells
of the immune
system, could change
the way
the antibody
worked.
||
Free Annual Subscription to The Humanion Portable Daily For
Students: Workers: Unwaged: Journalism and Media Workers ||
||
Readmore
||
:::ω:::
||
reginehumanicsfoundation.com
||
140121
|| Up ||
||
Tuesday: January 12: 2021 || ά. A shadow over the promising inhaled
interferon beta COVID-19 therapy has been cleared with the discovery that,
although, it appears to increase levels of ACE2 protein, that the
coronavirus uses as the key entry point into the nose and lung cells, it,
predominantly, increases the levels of a short version of that protein, as
opposed to its long version, which the virus can not bind to.
The virus that causes COVID-19, known as SARS-CoV-2, enters the nose and
lung cells through binding of its spike protein to the cell surface protein,
angiotensin converting enzyme two:ACE2. Now a new, short form of ACE2 has
been identified by Professor Jane Lucas, Professor Donna Davies, Dr
Gabrielle Wheway and Dr Vito Mennella at the University of Southampton and
University Hospital Southampton
NHS
Foundation Trust.
||
Free Annual Subscription to The Humanion Portable Daily For
Students: Workers: Unwaged: Journalism and Media Workers ||
||
Readmore
||
:::ω:::
||
reginehumanicsfoundation.com
||
130121
|| Up ||
| | |